• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从ONTARGET和TRANSCEND研究的角度看药物依从性的重要性。

Importance of medication adherence from the ONTARGET and TRANSCEND points of view.

作者信息

Barrios Vivencio, Escobar Carlos, Echarri Rocio

机构信息

Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain.

出版信息

Fundam Clin Pharmacol. 2009 Apr;23(2):259-60. doi: 10.1111/j.1472-8206.2009.00683.x. Epub 2009 Mar 9.

DOI:10.1111/j.1472-8206.2009.00683.x
PMID:19298232
Abstract

Medication adherence is crucial to improve the prognosis of patients with hypertension. Importantly, the variables associated with antihypertensive medication withdrawal do not occur immediately after the cessation, but likely in the following years. Nevertheless, since the current randomized clinical trials are limited to a short or mid follow-up, the results provided from these studies cannot exactly reflect the importance of the therapy discontinuation. We discuss about two recent examples, the ONTARGET and the TRANSCEND trials, in which the inclusion of the discontinuation rates in the primary analysis change the results of these studies and subsequently, the interpretation of the data.

摘要

药物依从性对于改善高血压患者的预后至关重要。重要的是,与停用抗高血压药物相关的变量并非在停药后立即出现,而是可能在接下来的几年中出现。然而,由于目前的随机临床试验仅限于短期或中期随访,这些研究提供的结果不能准确反映治疗中断的重要性。我们讨论两个最近的例子,即ONTARGET试验和TRANSCEND试验,其中在主要分析中纳入停药率改变了这些研究的结果,进而改变了数据的解释。

相似文献

1
Importance of medication adherence from the ONTARGET and TRANSCEND points of view.从ONTARGET和TRANSCEND研究的角度看药物依从性的重要性。
Fundam Clin Pharmacol. 2009 Apr;23(2):259-60. doi: 10.1111/j.1472-8206.2009.00683.x. Epub 2009 Mar 9.
2
First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.韩国开始使用抗高血压药物的门诊患者的第一年治疗依从性:一项回顾性索赔审查结果
Clin Ther. 2009 Jun;31(6):1309-20. doi: 10.1016/j.clinthera.2009.06.011.
3
Impact of supportive measures on drug adherence in patients with essential hypertension treated with valsartan: the randomized, open-label, parallel group study VALIDATE.缬沙坦治疗原发性高血压患者时支持性措施对药物依从性的影响:随机、开放标签、平行组研究VALIDATE
J Hypertens. 2009 Apr;27(4):894-901. doi: 10.1097/HJH.0b013e328323f9be.
4
Does synchronizing initiation of therapy affect adherence to concomitant use of antihypertensive and lipid-lowering therapy?同步开始治疗是否会影响抗高血压和降脂治疗联合使用的依从性?
Am J Ther. 2009 Mar-Apr;16(2):119-26. doi: 10.1097/MJT.0b013e31816b69bc.
5
Physicians' ability to predict patients' adherence to antihypertensive medication in primary care.基层医疗中医生预测患者抗高血压药物依从性的能力。
Hypertens Res. 2008 Sep;31(9):1765-71. doi: 10.1291/hypres.31.1765.
6
Poor blood pressure control: what physicians can do to improve it.血压控制不佳:医生可采取哪些措施来改善
Postgrad Med. 2000 Oct;108(5 Suppl):19-24. doi: 10.3810/pgm.10.2000.suppl8.47.
7
Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.联合治疗优化高血压管理:执业护士的考量因素
J Cardiovasc Nurs. 2009 Sep-Oct;24(5):380-9. doi: 10.1097/JCN.0b013e3181aed18e.
8
Apparent resistant hypertension and medication adherence.显性难治性高血压与药物依从性。
Hypertens Res. 2011 Jan;34(1):41-2. doi: 10.1038/hr.2010.216. Epub 2010 Nov 25.
9
Adherence to medication: the importance of research in primary care.药物依从性:初级保健研究的重要性。
Am J Hypertens. 2010 Feb;23(2):109. doi: 10.1038/ajh.2009.205.
10
Managing 'resistance': is adherence a target for treatment?应对“耐药性”:坚持治疗是治疗目标吗?
Curr Opin Nephrol Hypertens. 2014 Sep;23(5):439-43. doi: 10.1097/MNH.0000000000000045.

引用本文的文献

1
Manidipine: an antihypertensive drug with positive effects on metabolic parameters and adrenergic tone in patients with diabetes.马尼地平:一种对糖尿病患者的代谢参数和肾上腺素能张力有积极作用的降压药物。
Drugs Context. 2018 Jan 3;7:212509. doi: 10.7573/dic.212509. eCollection 2018.